Minireviews
Copyright ©The Author(s) 2021.
World J Hepatol. Nov 27, 2021; 13(11): 1707-1726
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1707
Table 5 Management during evaluation in acute phase
Following thumb rules while attending to a patient with suspected mitochondrial disorder
Monitor closely for hypoglycemia and acidosis
Avoid lactated ringer’s solution for fluid administration: Worsens acidosis
Bicarbonate infusions as 1st line of defense
Avoid propofol for sedation/anesthesia
Avoid fasting > 12 h; avoid high rate glucose only infusions
Avoid drugs that are toxic to mitochondria: Chloramphenicol, valproate, aminoglycosides, phenytoin, carbamazapine, phenobarbital, statins, linezolid
Avoid drugs precipitating hepatopathy/liver dysfunction